VSI Fall 2014 Newsletter

Bibliography

American Academy of Dermatology Association. Background Information for the 2014 Legislative Conference: Patient access to care and network adequacy. p. 40.

American Dental Association. Oral Health Topics: Medicaid and Medicare. http://www.ada.org/en/member-center/oral-health-topics/medicaid-and-medicare.

Beheshti A, Ghadami H, Barikani A, Haj Manouchehri F. Assessment of vitamin D plasma levels in patients with vitiligo vulgaris.
Acta Med Iran. 2014 Aug;52(8):601-6.

Caffeine Content. Facts about Caffeine Content of White Tea. http://www.caffeine-content.com/caffeine-in-tea/caffeine-in-white-tea/.

CBC News. Green tea up to 5 times as healthy when citrus juice added. Last Updated: Nov 14, 2007. http://www.cbc.ca/news/technology/green-tea-up-to-5-times-as-healthy-when-citrus-juice-added-1.650899.

Colucci R, Lotti F, Dragoni F, Arunachalam M, Lotti T, Benvenga S, Moretti S. High prevalence of circulating autoantibodies against thyroid hormones in vitiligo and correlation with clinical and historical parameters of patients. Br J Dermatol. 2014 Jul 24. doi: 10.1111/bjd.13286. [Epub ahead of print].

Falabella R. Vitiligo and the melanocyte reservoir. Indian J Dermatol. 2009 Oct-Dec;54(4):313-18.

Gianfaldoni S, Zanardelli M, Lotti T. Vitiligo Repigmentation: What's New? J Dermatolog Clin Res 2(3):1023.

Green Tea Health News. Decaffeinated Green Tea. http://www.green-tea-health-news.com/decaffeinated-green-tea.html.

Jang HM, Erf GF, Rowland KC, Kong BW. Genome resequencing and bioinformatic analysis of SNP containing candidate genes in the autoimmune vitiligo Smyth line chicken model. BMC Genomics. 2014 Aug 23;15(1):707.

Karadag AS, Tutal E, Ertugrul DT. Insulin resistance is increased in patients with vitiligo. Acta Derm Venereol. 2011 Sep;91(5):541-4.

Karadag AS, Tutal E, Ertugrul DT, Akin KO, Bilgili SG. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo. Clin Exp Dermatol. 2012 Jan;37(1):62-4.

Kulash T. UnitedHealthcare cuts Missouri physicians from Medicare Advantage. St. Louis Post-Dispatch. June 18, 2014. http://www.stltoday.com/news/special-reports/mohealth/unitedhealthcare-cuts-missouri-physicians-from-medicare-advantage/article_b4cca6be-6bc1-5c74-96aa-88f96cd6dd31.html.

Mayo Clinic. Caffeine Content for Coffee, Tea, Soda, and More. May 13, 2014. http://www.mayoclinic.org/healthy-living/nutrition-and-healthy-eating/in-depth/caffeine/art-20049372.

Dr. Mercola. What’s in Your Green Tea? July 3, 2013. http://articles.mercola.com/sites/articles/archive/2013/07/03/green-tea-benefits.aspx.

National Cancer Institute Factsheet: Tea and Cancer Prevention: Strengths and Limits of the Evidence. http://www.cancer.gov/cancertopics/factsheet/prevention/tea.

Noel M, Gagne C, Bergeron J, Jobin J, Poirer P. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis. 2004 May: 10:3-7.

Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004 Jan;50(1):63-7.

Pietrzak A, Bartosinska J, Dybiec E, Chodorowska G, Krasowska D, Hercogovat J, Lotti T. Hepato-splenic and lipid profile abnormalities—do they exist in children affected with vitiligo? Acta Dermatovenerol Croat. 2014 Apr;22(1):19-25.

Pietrzak A, Bartosinska J, Hercogovat J, Lotti TM, Chodorowska G. Metabolic syndrome in vitiligo. Dermatol Ther. 2012 Nov-Dec;25 Suppl 1:S41-3.

Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. J Am Acad Dermatol. 2011:64:445-7.

Singh S, Singh U, Pandey SS. Increased level of serum homocysteine in vitiligo. J Clin Lab Anal. 2011;25(2):110-2.

Ustun I, Serastan G, Gokce C, Motor S, Can Y, Ugur Inan M, Yilmaz N. Investigation of vitamin D levels in patients with vitiligo vulgaris. Acta Dermatovenerol Croat. 2014 Jul:22(2):110-3.

Ware, Jr. JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). Medical Care Volume 30, No. 6 (June 1992). pp-473-483. Lippincott Williams & Wilkins. http://www.jstor.org/discover/10.2307/3765916?uid=3739920&uid=2&uid=4&uid=3739256&sid=21104748096253.

Yang Y, Huang G, Yan X, Qing Z. Clinical analysis of thyroglobulin antibody and thyroid peroxidase antibody and their association with vitiligo. Indian J Dermatol. 2014 Jul;59(4):357-60.

Zhu Y, Wang S, Lin F, Li Q, Xu A. The therapeutic effects of EGCG on vitiligo. Fitoterapia. 2014 Aug 12. pii: S0367-326X(14)00221-4. doi: 10.1016/j.fitote.2014.08.007. [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/25128425.